Skathi ™ as the first successful commercial product independently developed and produced by KAI MedTech, the distal access catheter has been approved by NMPA to be listed in China in July 2021, and has been fully affirmed by many domestic neurointerventional physicians with stable and excellent clinical performance in less than a year.

The catheter licensed by FDA 510 (k) this time is produced and sold by the US subsidary of KAI Medtech. The product design and production process are consistent with its version in China, showing its excellent product performance and high standard production system of KAI Medtech. At the same time, it also highlights the solid and efficient technology platform and global strategic layout of KAI MedTech.